The Group has been pioneer in innovation; Ratan Tata has been credited for launching world's cheapest car Nano in 2009
Last week, Sun's Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration's approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis.
The shrinkage of MTS operations has helped Tata Tele's wireless net service brand to gain traction.
Compulsory licence application filed for anti-cancer drug of Bristol Myers Squibb; more to come for four drugs.
Brian Druker, who invented the drug's molecule, says it would benefit patients in the short term.
Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.
The Cellular Operators Association of India, industry body representing GSM operators, had argued that TTSL's spectrum was allotted through the same press release issued on January 10, 2008, which led to the cancellation of 122 licences.
In some cases fake degrees and certificates were uncovered.
As funding from foreign private equity and venture capital firms is the lifeline for most online retailers, the restriction on foreign direct investment is threatening to block any fresh investment into the sector.
Interview with Richard Rekhy, chief executive officer of KPMG India.
Experts say successful brand extensions require a sharply defined unifying thread and Tata Chemicals may have faltered on that.
In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.
Vodafone India MD & CEO Marten Pieters, 59, blames regulation and the spectrum policy for the telecom industry's troubles.
Past two years have witnessed a churn, mainly in the area of mergers and acquisitions.
Fixes spotlight on in-house talent for retaining and grooming purposes.
The plan is to issue CLs for Trastuzumab (or Herceptin, used for treating breast cancer), Ixabepilone (used for chemotherapy in breast cancer treatment) and Dasatinib (or Sprycel, for leukaemia).
Sets up new financial services arm, Amit Goenka joins as CEO.
Since price is a big stumbling block, the company is looking at assembly of Evoque in India.
Golden Eagle was first launched 12 years ago, but the Ghaziabad-headquartered company stopped marketing the product a few years ago, to focus totally on its alcoholic division.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances